NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Genital tract inflammation (GTI) in HIV infected women.

Mayer KH; National Conference on Human Retroviruses and Related Infections.

Program Abstr Second Natl Conf Hum Retrovir Relat Infect Natl Conf Hum Retrovir Relat Infect 2nd 1995 Wash DC. 1995 Jan 29-Feb 2; 153.

Brown University, Providence, RI.

Objective: To describe the prevalence and factors associated with GTI in HIV+ and HIV- women. Methods: Interviews, physical exams, and lab studies [including cervicovaginal lavage (CVL) WBC, as measured by hemocytomer] were obtained from 228 HIV+ and 145 high risk, demographically-matched HIV- women from the initial visit of this prospective women's cohort study and were analyzed. Results: 49% of the women were HIV-infected by sex; 71% were ethnic/racial minorities; over 2/3 were 26-40 y.o; 46% reported a prior STD. The most common genital tract infections on exam were bacterial vaginosis (31%); candidiasis (14%); trichomoniasis (12%); chlamydia (4%); HPV by PCR (54%). The mean WBC in CVLs were 835 (range: 0-99, 396) in HIV+ and 216 (range: 0- 2,000) in HIV- women (p=0.26). CVL WBC tended to be higher in women with STDs, with an IDU history, who had not douched within 48 hours prior to exam, and who had recently menstruated, but the differences were not significant (NS) even when stratified by HIV status. Conclusions: HIV+ women tended to have higher CVL WBC counts than HIV- women although the differences were NS; increased CVL WBC may be due to different GU tract exposures.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Case-Control Studies
  • Cohort Studies
  • Female
  • HIV
  • HIV Antibodies
  • HIV Core Protein p24
  • HIV Infections
  • HIV Seronegativity
  • HIV Seropositivity
  • Humans
  • Longitudinal Studies
  • Prevalence
  • Sexually Transmitted Diseases
  • Trichomonas Infections
  • Vaginosis, Bacterial
  • immunology
Other ID:
  • 95920561
UI: 102213510

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov